Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
1 clinical trials · Condition
◉ Watch Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
| Record | Firm | Date |
|---|---|---|
| Managed Access Programs for LDK378, Ceritinib (NCT05100134) | Novartis Pharmaceuticals |
Track Anaplastic Lymphoma Kinase (ALK)- Positive Tumors automatically
Every clearance here is in the API, with alerts when new ones post.